Konjac mannan

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Konjac mannan
Accession Number
DB14963
Type
Small Molecule
Groups
Investigational
Description

Konjac mannan is under investigation in clinical trial NCT01709955 (The Effects of Glucomannan on Weight Loss).

Synonyms
  • GLUCOMANNAN
Categories
UNII
36W3E5TAMG
CAS number
37220-17-0
Weight
Not Available
Chemical Formula
Not Available
InChI Key
Not Available
InChI
Not Available
IUPAC Name
Not Available
SMILES
Not Available

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteraction
AcetazolamideThe risk or severity of adverse effects can be increased when Acetazolamide is combined with Konjac mannan.
AgmatineThe therapeutic efficacy of Konjac mannan can be decreased when used in combination with Agmatine.
AlfentanilThe therapeutic efficacy of Konjac mannan can be decreased when used in combination with Alfentanil.
AlphacetylmethadolThe therapeutic efficacy of Konjac mannan can be decreased when used in combination with Alphacetylmethadol.
AlphaprodineThe therapeutic efficacy of Konjac mannan can be decreased when used in combination with Alphaprodine.
AmilorideThe risk or severity of adverse effects can be increased when Amiloride is combined with Konjac mannan.
AmiodaroneThe therapeutic efficacy of Konjac mannan can be decreased when used in combination with Amiodarone.
AmlodipineThe therapeutic efficacy of Konjac mannan can be decreased when used in combination with Amlodipine.
AranidipineThe therapeutic efficacy of Konjac mannan can be decreased when used in combination with Aranidipine.
AzelnidipineThe therapeutic efficacy of Konjac mannan can be decreased when used in combination with Azelnidipine.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

References

General References
Not Available
External Links
Not Available

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedTreatmentFunctional Gastrointestinal Disorders1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Classification
Not classified

Drug created on May 20, 2019 08:38 / Updated on May 21, 2019 12:32